A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Mannkind Corp stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 197,736 shares of MNKD stock, worth $1.36 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
197,736
Previous 184,243 7.32%
Holding current value
$1.36 Million
Previous $961,000 29.14%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.01 - $6.7 $67,599 - $90,403
13,493 Added 7.32%
197,736 $1.24 Million
Q2 2024

Aug 14, 2024

BUY
$4.05 - $5.43 $746,184 - $1 Million
184,243 New
184,243 $961,000

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.77B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Mirae Asset Global Etfs Holdings Ltd. Portfolio

Follow Mirae Asset Global Etfs Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Etfs Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Etfs Holdings Ltd. with notifications on news.